A New Canadian Plant-Based COVID-19 Vaccine Is Looking For 30,000 People For Testing
On Tuesday, March 16, Quebec-based Medicago announced that they will be moving into Phase 3 of clinical testing of their plant-based COVID-19 vaccine candidate.
Medicago's COVID-19 vaccine candidate is "plant-derived," and, as it moves to late-stage clinical testing, 30,000 people will be able to volunteer for the trials.
Editor's Choice: Here Are All The Essential Workers Who Can Get Vaccines First In Ontario
"The trial will take place in 10 countries pending regulatory approvals, starting with Canada and the United States," said a press release.
They'll be testing a range of "males and females from ethnically and racially diverse populations."
You must be over the age of 18 to apply and must not have received a COVID-19 vaccine or diagnosis.
Health Canada has a robust website with all the latest information on the vaccines and can answer any questions you may have. Click here for more information.